Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Xigduo Xr

Dapaglifloz Propaned/Metformin

Open in the dashboard

Part D claims

141,978

Prescriptions dispensed, refills included

Drug cost

$124,508,349

Paid at the pharmacy, in all

Prescribers

4,747

With 11 or more claims of it

In 2024, Medicare Part D recorded 141,978 claims for Xigduo Xr (dapaglifloz propaned/metformin) from 4,747 prescribers, at a total drug cost of $124.5 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 51 states and territories
Part D claims for Xigduo Xr by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
PR 541 26,747 $19,925,471
TX 744 20,795 $20,655,525
NY 316 12,095 $11,642,204
CA 363 11,947 $9,953,894
FL 245 6,279 $5,565,869
NJ 164 5,384 $5,479,314
MS 179 5,311 $4,453,957
AL 184 4,748 $4,016,262
NC 178 4,405 $3,748,848
TN 168 4,095 $3,347,534
LA 138 3,602 $2,675,839
GA 136 3,474 $3,293,674
PA 104 2,639 $2,298,814
SC 111 2,580 $2,516,663
KY 85 2,312 $2,003,462
The other 36 states and territories
State Prescribers Claims Drug cost
OK 72 1,964 $1,671,181
IN 86 1,822 $1,634,281
MO 71 1,814 $1,538,509
MI 52 1,685 $1,370,430
IL 66 1,604 $1,381,035
MD 73 1,548 $1,692,350
OH 66 1,519 $1,362,482
VA 53 1,327 $1,299,441
AR 66 1,255 $891,589
KS 58 1,133 $796,537
AZ 48 1,009 $1,094,715
NV 34 955 $979,345
HI 28 784 $934,822
UT 40 738 $676,415
WA 28 724 $667,151
NE 32 696 $468,624
CT 27 595 $686,031
IA 22 594 $455,199
MA 24 527 $433,492
ID 18 462 $447,956
CO 18 449 $407,907
NM 17 403 $342,791
WV 12 338 $288,084
WI 16 316 $258,901
SD 15 274 $203,953
DE 9 226 $273,762
AK 5 162 $189,534
ND 8 146 $96,703
MN 5 132 $108,160
MT 6 104 $52,144
OR 6 83 $70,040
NH 3 52 $43,997
WY 3 50 $37,670
DC 2 45 $40,658
RI 1 15 $11,448
ME 1 15 $23,686

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 36
Part D claims for Xigduo Xr by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Internal Medicine 1,159 35,394 $30,996,029
Family Practice 1,323 32,871 $27,960,997
Endocrinology 671 31,290 $29,624,023
Nurse Practitioner 810 19,999 $17,609,028
General Practice 276 9,858 $7,607,931
Physician Assistant 341 8,299 $7,308,406
Cardiology 35 1,019 $835,528
Nephrology 30 886 $665,752
Geriatric Medicine 14 548 $413,350
Emergency Medicine 11 302 $231,002
Pharmacist 13 290 $266,547
Pediatric Medicine 9 153 $151,123
Student in an Organized Health Care Education/Training Program 6 136 $79,463
Specialist 5 125 $126,870
Certified Clinical Nurse Specialist 6 123 $126,813

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Eliscer Guzman Internal Medicine NY 730 $663,771 None on record
Edwin Torres Nurse Practitioner NY 538 $458,183 None on record
Alex Gonzalez Bossolo Endocrinology PR 531 $491,296 None on record
Sheila Mercado Endocrinology PR 458 $307,102 None on record
Hernan Baquerizo Endocrinology FL 447 $406,284 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for dapaglifloz propaned/metformin

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record